MILWAUKEE, Aug. 9, 2024 -- Ademi LLP is investigating Iteris (NASDAQ: ITI) for possible breaches of fiduciary duty and other violations of law in its transaction with Almaviva.
Click here to learn how to join our investigation https://www.ademilaw.com/case/iteris-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
Iteris stockholders will receive only $7.20 in cash for each share of Iteris common stock valuing Iteris at approximately $335 million equity value. The transaction agreement unreasonably limits competing transactions for Iteris by imposing a significant penalty if Iteris accepts a competing bid. Iteris insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of Iteris' board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
If you own Iteris common stock and wish to obtain additional information, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, or https://www.ademilaw.com/case/iteris-inc
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology.
